PinnyPeptide

Pancragen vs Testagen

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Pancragen

Bioregulators

Khavinson short peptide bioregulator targeting pancreatic tissue and glucose metabolism.

Peptide B

Testagen

Bioregulators

Khavinson short peptide bioregulator targeting testicular tissue.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Pancragen effects

  • Reported support of residual β-cell function
  • Improvements in fasting glucose and HbA1c (Russian observational)
  • Support of exocrine pancreatic function
  • Improvement in digestion in pancreatic insufficiency
  • Modulation of pancreatic gene expression

Testagen effects

  • Reported support of Leydig cell testosterone production
  • Possible improvement in sperm parameters
  • Support of overall reproductive function
  • Anti-inflammatory effects in testicular tissue
  • Modulation of testicular gene expression

Pancragen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Should not substitute for proven diabetes therapies

Testagen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Should not substitute for proper hypogonadism evaluation

Pancragen dosing ranges

Pancreatic support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Testagen dosing ranges

Reproductive support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Pancragen vs Testagen — common questions

What is the difference between Pancragen and Testagen?

Pancragen: Khavinson short peptide bioregulator targeting pancreatic tissue and glucose metabolism. Typical dose 1,000-5,000 mcg. Testagen: Khavinson short peptide bioregulator targeting testicular tissue. Typical dose 1,000-5,000 mcg. Both fall under the Bioregulators category.

Can you stack Pancragen and Testagen?

Stacking Pancragen with Testagen is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Pancragen or Testagen?

Pancragen is typically dosed: Once daily (SubQ) or sublingual for Pancreatic support. Testagen is typically dosed: Once daily (SubQ) or sublingual for Reproductive support.

Are Pancragen and Testagen FDA approved?

Pancragen: Not FDA approved. Testagen: Not FDA approved.

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free